Elanco: Past, Present and Future
Since our start, Elanco has worked to empower veterinarians, farmers, and all those caring for animals with the tools needed to help animals live healthy lives.
A Legacy of Innovation
For nearly 70 years, we've focused on delivering innovative animal health solutions that solve our customers’ greatest challenges.
1950-1989
Where it All Began
Elanco has helped shape the lives of animals and their care providers for more than half a century.
1953
The Beginning of Elanco Animal Health
Eli Lilly and Company introduces the first antibiotic exclusively for veterinary use.
1955
Agricultural and Veterinary Medicine Research Center
Eli Lilly and Company purchases acreage adjoining the Biological Laboratories of Greenfield, Ind. The facility is completed in 1959 and opens as the Agricultural and Veterinary Medicine Research Center.
1956
Expanding Products
With the purchase of Corn State Laboratories, Lilly expands its line of veterinary products.
1960
Growing Rapidly
In 1960, Elanco began growing rapidly into new countries and markets.
1970s
Growing Business and Products
Elanco continues its global expansion and changes its identity with a bold new logo.
1980s
New Research Focus
Research and development shifts from plant science toward animal health, specifically on increasing the quality of animal-sourced protein.
1990-2000
2000-2010
2007
Bringing Employees Together
Elanco builds a dedicated global headquarters campus in Greenfield, Ind., bringing together employees from all areas of the company for the first time.
2007
Growing Through Acquisition
Elanco launches Companion Animal parasiticides and acquires long-term partner Ivy Animal Health and launches its Pet Animal businesses.
2007
Elanco adds Monsanto Dairy Business
2011-2020
2010
European Expansion
Expands European business: Pfizer vaccines
2011
Elanco acquires Janssen Animal Health.
2012
A Growing Portfolio
With the acquisition of ChemGen, Elanco obtains a portfolio of feed enzyme products for poultry, egg and meat production.
2013
Global Growth and Product Expansion
Elanco's Pet portfolio grows and en
2014
Global Poultry Leader
Elanco acquires Lohmann Animal Health and becomes a global leader in poultry.
2015
Leading Animal Health
Elanco acquires Novartis Animal Health. The combined organization is committed to leading the animal health industry in delivering innovation and customer value.
2016
U.S. Expansion
Elanco expands its U.S. pet health portfolio by acquiring an innovative platform of vaccines from Boehringer Ingelheim Vetmedica.
2018
The New, Independent Elanco
Elanco lists on the New York Stock Exchange (NYSE:ELAN), separating from Lilly and giving its employees ownership.
2019
Elanco's Healthy Purpose™
Elanco launches its Healthy Purpose™ initiative: its corporate social responsibility platform, and commitment to realizing its vision of Food and Companionship Enriching Life.
Elanco Foundation
Elanco establishes the Elanco Foundation, which is the first-ever charitable foundation in animal health.
Elanco Completes Separation from Lilly
Elanco becomes a fully-independent pure play animal health company.
2020
Elanco Closes Acquisition of Bayer Animal Health
Elanco, now with the addition of Bayer Animal Health, has improved capabilities, scale and global reach to position the company as a long-term leader in the growing global animal health market.
2021 to date
2021
ESG Summary Report
Elanco releases its first independent ESG Summary Report
Building a healthy enterprise and driving sustainability are essential to our success and leadership in animal health.
— Todd Young, executive vice president and CFO
Elanco closes acquisition of Kindred Biosciences
The transaction advances Elanco’s access to the fast-growing $1+ billion dermatology market, complementing the company’s existing pipeline and increasing R&D capability in biologics and monoclonal antibodies.
Animals are the Answer
Sustainable Solutions for Zero Hunger by 2030: A Vision for Animal Agriculture Forum to explore solutions to combat climate change while keeping the world nourished.
Elanco Selected for 2021 FORTUNE’s Change the World List
FORTUNE's list recognizes companies that have made an important social or environmental impact through their profit-making strategy and operations.
2022
MAHABA (Managing Animal Health and Acaricides for a Better Africa)
Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa
Elanco and Ginkgo Bioworks Launch BiomEdit
A new Animal Health Company Leveraging Microbiome Technology
Elanco Breaks Ground on new Headquarters
Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark
You Might Be Interested In
Get to know Elanco, our hiring process and our people’s contributions to the well-being of animals.
Purpose-Driven Culture
Learn how we foster a culture that's driven by values and celebrates our company purpose.
Our People
Read about the individuals who shape Elanco and bring our culture and values to life.
Our Initiatives
See how we advance our vision of Food and Companionship Enriching Life through participation in programs and community projects.
What's Happening
About Elanco
Learn why we're a leading provider of innovative solutions that protect and enhance animal health.
Read About ElancoElanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco or its affiliates.
EM-GLB-CA-20-0041